Cantech Holding Inc (BSSP)
0.00
USD |
OTCM |
May 16, 16:00
Cantech Cash from Financing (TTM): 0.2179M for Sept. 30, 2015
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
September 30, 2015 | 0.2179M |
June 30, 2015 | 0.2508M |
March 31, 2015 | 0.2759M |
December 31, 2014 | 0.2321M |
September 30, 2014 | 0.1492M |
June 30, 2014 | 0.1535M |
March 31, 2014 | 0.1533M |
December 31, 2013 | 0.1271M |
Date | Value |
---|---|
September 30, 2013 | 0.1153M |
June 30, 2013 | 0.0765M |
March 31, 2013 | 0.0364M |
December 31, 2012 | 0.0369M |
September 30, 2012 | 0.0385M |
June 30, 2012 | 0.0952M |
March 31, 2012 | 0.0852M |
December 31, 2011 | 0.0851M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.313M |
Palatin Technologies Inc | 14.71M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.68M |
Oragenics Inc | 0.2839M |